Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Acetylenic aryl sulfonate hydroxamic acid TACE and matrix metalloproteinase inhibitors

Acetylenic aryl sulfonate hydroxamic acid TACE and matrix metalloproteinase inhibitors

US Patent 7199155 · Granted Apr 3, 2007

Estimated economic value: $140,808,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Beta-sulfonamide hydroxamic acid inhibitors of tace/matrix metalloproteinase2009
Alkynyl-containing tryptophan derivative inhibitors of TACE/matrix metalloprotei2009
Method for the treatment of polycystic kidney disease2009
Acetylenic aryl sulfonate hydroxamic acid tace and matrix metalloproteinase inhi2009
Acetylenic aryl sulfonate hydroxamic acid tace and matrix metalloproteinase inhi2009
Biaryl sulfonamides and methods for using same2008
Method for preparing hydroxamic acids2007
Preparation and use of acetylenic ortho-sulfonamido and phosphinic acid amido bi2005
Crystalline TNF-α-converting enzyme and uses thereof2005
Alkynyl containing hydroxamic acid compounds as matrix metalloproteinase and TAC2004
Acetylenic &agr;-amino acid-based sulfonamide hydroxamic acid tace inhibitors2004
Acetylenic &agr;-amino acid-based sulfonamide hydroxamic acid tace inhibitors2004